Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force

  title={Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force},
  author={Carrie D. Patnode and Jillian T. Henderson and Jamie H. Thompson and Caitlyn A. Senger and Stephen P. Fortmann and Evelyn P. Whitlock},
  journal={Annals of Internal Medicine},
Cigarette smoking and exposure to smoke result in more than 480000 premature deaths in the United States every year, along with substantial illness (1, 2). Despite considerable progress in tobacco control over the past 50 years, in 2013, an estimated 17.8% of U.S. adults (3) and 15.9% of pregnant women aged 15 to 44 years were current cigarette smokers (4). Many tools are available to help smokers quit, including counseling by health care providers, telephone- and print-based interventions… 
Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement.
  • A. Siu
  • Medicine, Psychology
    Annals of internal medicine
  • 2015
The current evidence is insufficient to recommend electronic nicotine delivery systems for tobacco cessation in adults, including pregnant women, and the USPSTF recommends that clinicians direct patients who smoke tobacco to other cessation interventions with established effectiveness and safety.
Going Slow May Not Be Best When Quitting Smoking
It is suggested that gradual cessation may be inferior to abrupt cessation in this trial because fewer patients in the gradual-cessation group returned for the prequit visit and completed a quit attempt than those in the abrupt-cessations group, and these findings are supported by population data.
Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Pregnant Women
People should not fear nicotine more than carbon monoxide and the deleterious products of combustion: Plasma nicotine levels are steady and lower with a 21-mg patch than with smoking, and peaks are avoided.
Quitting Smoking Among Adults - United States, 2000-2015.
During 2000-2015, increases occurred in the proportion of smokers who reported a past-year quit attempt, recently quit smoking, were advised to quit by a health professional, and used cessation counseling and/or medication (p<0.05).
An update on the pharmacotherapeutic interventions for smoking cessation
A clear understanding of appropriate dosing, regimen, technique, disadvantages, advantages, warnings/precautions, and contraindications for available pharmacotherapeutic options is essential in helping patients quit smoking.
Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women Symbol
The US Preventative Services Task Force (USPSTF) 2015 guideline recommends pharmacologic therapy for all nonpregnant persons who smoke in addition to behavioral counseling, andAlternative tobacco cessation options and potential new pharmacologic tobacco cessation agents are discussed.
Are electronic nicotine delivery systems helping cigarette smokers quit? Evidence from a prospective cohort study of U.S. adult smokers, 2015–2016
It is found that ENDS use, within context of the 2015–2016 US regulatory and tobacco/vaping market landscape, helped adult smokers quit at rates higher than smokers who did not use these products.
Health Benefits and Cost-Effectiveness of Brief Clinician Tobacco Counseling for Youth and Adults
The lifetime health and economic value of annually Counseling youth to discourage smoking initiation and of annually counseling adults to encourage cessation are assessed to help clinicians and care systems determine the priority for tobacco counseling in busy clinic schedules.
Smoking cessation: A public health necessity and every pharmacist’s concern
An overview of the pharmacological and non-pharmacological treatment interventions is provided, with a focus on the application of smoking cessation interventions in routine practice to ensure successful quitting.
Smoking cessation in pregnancy: An update for maternity care practitioners
It is important for the latest guidance to be put into practice, in all maternity care settings, in order to decrease rates of smoking in pregnancy and improve pregnancy outcomes.


Tobacco use screening and counseling during physician office visits among adults--National Ambulatory Medical Care Survey and National Health Interview Survey, United States, 2005-2009.
Clinicians and health-care systems often do not screen for and treat tobacco use consistently and effectively, and many patients do not achieve abstinence after their first attempt to quit, and they often require repeated cessation interventions.
Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement.
The net benefits of tobacco cessation interventions in adults and pregnant women remain well established and the 2003 U.S. Preventive Services Task Force recommendation on counseling to prevent tobacco use is reaffirmed.
Pharmacological interventions for promoting smoking cessation during pregnancy.
The primary efficacy outcome was smoking cessation in later pregnancy (in all but one trial, at or around delivery); safety was assessed by 11 outcomes that indicated neonatal and infant well-being; and adherence with trial NRT regimens was low.
Behavioral counseling and varenicline treatment for smoking cessation.
A review of the evidence on technology-based interventions for the treatment of tobacco dependence in college health.
  • J. Brown
  • Medicine
    Worldviews on evidence-based nursing
  • 2013
Use of technology-based interventions, such as the Internet, may be an effective tool for tobacco treatment interventions, especially with college students, and there was a statistically significant improvement in quit rates.
Pharmacologic-based strategies for smoking cessation: clinical and cost-effectiveness analyses.
Compared the pharmacological agents (drug-based smoking cessation aids) to determine which of these works best (clinical effectiveness) at six months and 12 months after patients attempt to quit smoking, from the perspective of a publicly funded health care system.
Current Cigarette Smoking Among Adults — United States, 2005–2013
Estimates of cigarette smoking prevalence among adults aged ≥18 years and among lesbian, gay, or bisexual persons using NHIS data are provided to assess progress made toward the Healthy People 2020 target of reducing the proportion of U.S. adults who smoke cigarettes to ≤12.0% (objective TU-1.1).
Medicaid provider delivery of the 5A's for smoking cessation counseling.
Medicaid needs to (a) increase provider delivery of the full spectrum of counseling interventions recommended for smoking cessation and (b) extend provider outreach to the demographic groups that receive the lowest rates of counseling.
Smoking-cessation interventions for U.S. young adults: a systematic review.